Company: INDP
Filing Date: 2025-09-02
Form Type: S-1
Source: 0001493152-25-012531
Chunk: 32

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-09-02
Form: S-1
Chunk 32
---
 offering were subject to market conditions and negotiations between us, the Placement Agent and prospective investors. This is a best efforts offering and there is no minimum offering amount required as a condition to the closing of this offering. Because there is no minimum offering amount required as a condition to closing this offering, we may sell fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received by us. The Placement Agent does not guarantee that it will be able to raise new capital in any prospective offering. The Placement Agent may engage sub-agents or selected dealers to assist with the offering.

Investors purchasing securities offered hereby will have the option to execute a securities purchase agreement with us. In addition to rights and remedies available to all purchasers in this offering under federal securities and state law, the purchasers which enter into a securities purchase agreement will also be able to bring claims of breach of contract against us. The ability to pursue a claim for breach of contract is material to larger purchasers in this offering as a means to enforce (i) a covenant to not enter into variable rate financings for a period of six (6) months following the closing of the offering, subject to certain conditions and exceptions, and (ii) a covenant to not enter into any equity financings for thirty (30) days from closing of the offering, subject to certain exceptions. The nature of the representations, warranties and covenants in the securities purchase agreements shall include:

| ● | standard                                                                                             
 issuer representations and warranties on matters such as organization, qualification, authorization, 
 no conflict, no governmental filings required, current in SEC filings, no litigation, labor          
 or other compliance issues, environmental, intellectual property and title matters and compliance    
 with various laws such as the Foreign Corrupt Practices Act; and                                     |

| 16 |

| ● | covenants regarding matters such as registration of warrant shares, no integration with other offerings,                                
 no stockholder rights plans, no material nonpublic information, use of proceeds, indemnification of purchasers, reservation and listing 
 of shares of common stock, no subsequent equity sales for thirty (30) days from closing of the offering, subject to certain             
 exceptions, and an agreement to not enter into variable rate financings for six (6) months from closing, subject to certain             
 exceptions.                                                                                                                             |

The securities will be offered at a fixed price and are expected to be issued in a single closing. We expect this offering to be completed not later than one business day following the commencement of this offering, which will be the date